PTC Therapeutics (PTCT)

Common Shares
Sell: $74.78|Buy: $83.00|Change: 0.78 (1.03%)

Company profile

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Address

100 Corporate Court
South Plainfield
NJ
USA
07080


Telephone

+1 908 2227000


Sector 

Healthcare


Previous key dates

NameKey Date
44th Annual J.P. Morgan Healthcare Conference2026-01-12T12:00:00
Citi 2025 Global Healthcare Conference2025-12-04T10:30:00
R&D Day2025-12-02T09:30:00
Jefferies Global Healthcare Conference 20252025-11-18T03:00:00
UBS Global Healthcare Conference 20252025-11-11T15:30:00
PTC Therapeutics Inc Third Quarter Earnings Conference Call for 20252025-11-04T16:30:00
PTC Therapeutics Inc Third Quarter Earnings Results for 20252025-11-04T00:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-08T09:15:00
Wells Fargo 2025 Healthcare Conference2025-09-04T11:00:00
Cantor Global Healthcare Conference 20252025-09-03T08:35:00
PTC Therapeutics Inc Second Quarter Earnings Conference Call for 20252025-08-07T16:30:00
PTC Therapeutics Inc Second Quarter Earnings Results for 20252025-08-07T00:00:00
PTC Therapeutics Inc Annual General Meeting for 20252025-06-17T09:00:00
Goldman Sachs 46th Annual Global Healthcare Conference 20252025-06-10T09:20:00
William Blair 45th Annual Growth Stock Conference 20252025-06-03T10:20:00
RBC Capital Markets Global Healthcare Conference 20252025-05-20T14:05:00
Bank of America Securities 2025 Health Care Conference2025-05-13T13:00:00
PTC Therapeutics Inc First Quarter Earnings Conference Call for 20252025-05-06T16:30:00
PTC Therapeutics Inc First Quarter Earnings Result for 20252025-05-06T00:00:00
Barclays 27th Annual Global Healthcare Conference2025-03-11T12:30:00
TD Cowen 45th Annual Health Care 2025 Conference2025-03-04T11:10:00
PTC Therapeutics Inc Fourth Quarter Earnings Conference Call for 20242025-02-27T16:30:00
PTC Therapeutics Inc Fourth Quarter Earnings Result for 20242025-02-27T00:00:00
PTC Therapeutics Inc Annual Report for 20242025-02-27T00:00:00
2025 J.P. Morgan Healthcare Conference2025-01-13T14:15:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.